Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Trends in antibacterial use in hospitalized pediatric patients in United States academic health centers.

Pakyz AL, Gurgle HE, Ibrahim OM, Oinonen MJ, Polk RE.

Infect Control Hosp Epidemiol. 2009 Jun;30(6):600-3. doi: 10.1086/597545.

PMID:
19419328
2.

The impact of linezolid and vancomycin treatment on local signs and symptoms of inflammation among pediatric patients with complicated skin and skin structure infections.

Deville JG, Equils O, Huang DB, Ang JY.

Clin Pediatr (Phila). 2011 Nov;50(11):1064-7. doi: 10.1177/0009922810385107. Epub 2010 Nov 22. No abstract available.

PMID:
21098522
3.

Linezolid use in hospitalized children.

Hersh AL, Lee BR, Hedican EB, Herigon JC, Newland JG.

Pediatr Infect Dis J. 2014 Jan;33(1):e14-8. doi: 10.1097/INF.0000000000000011.

PMID:
24352192
4.

[How effective are linezolid and telithromycin? The resistance situation of pathogenic gram positive infections in Germany].

Kresken M.

Pharm Unserer Zeit. 2004;33(1):20-7. Review. German. No abstract available.

PMID:
14968709
5.

Antibiotic usage in a pediatric medical center.

Naqvi SH, Dunkle LM, Timmerman KJ, Reichley RM, Stanley DL, O'Connor D.

JAMA. 1979 Nov 2;242(18):1981-4.

PMID:
480644
6.

Use of linezolid in neonatal and pediatric inpatient facilities--results of a retrospective multicenter survey.

Simon A, Müllenborn E, Prelog M, Schenk W, Holzapfel J, Ebinger F, Klabunde-Cherwon A, Faber J, Groll AH, Masjosthusmann K, Dohna-Schwake C, Beutel K, Dirkwinkel E, Lehrnbecher T, Ammann RA, Müller A.

Eur J Clin Microbiol Infect Dis. 2012 Jul;31(7):1435-42. doi: 10.1007/s10096-011-1461-1. Epub 2011 Nov 3.

PMID:
22048844
7.

Linezolid: in infants and children with severe Gram-positive infections.

Lyseng-Williamson KA, Goa KL.

Paediatr Drugs. 2003;5(6):419-29; discussion 430-1. Review.

PMID:
12765493
8.

Emergence of linezolid-resistant coagulase-negative Staphylococcus in a cancer centre linked to increased linezolid utilization.

Mulanovich VE, Huband MD, McCurdy SP, Lemmon MM, Lescoe M, Jiang Y, Rolston KV, LaSala PR.

J Antimicrob Chemother. 2010 Sep;65(9):2001-4. doi: 10.1093/jac/dkq238. Epub 2010 Jun 25.

9.

Linezolid for the treatment of community-acquired pneumonia in hospitalized children. Linezolid Pediatric Pneumonia Study Group.

Kaplan SL, Patterson L, Edwards KM, Azimi PH, Bradley JS, Blumer JL, Tan TQ, Lobeck FG, Anderson DC; Linezolid Pediatric Pheumonia Study Group. Pharmacia and Upjohn.

Pediatr Infect Dis J. 2001 May;20(5):488-94.

PMID:
11368105
10.

Comment on: Successful treatment of methicillin-resistant Staphylococcus aureus mitral valve endocarditis with sequential linezolid and telavancin monotherapy following daptomycin failure.

Camou F.

J Antimicrob Chemother. 2012 Feb;67(2):514; author reply 515. doi: 10.1093/jac/dkr469. Epub 2011 Nov 11. No abstract available.

11.

Comment on: Successful treatment of methicillin-resistant Staphylococcus aureus mitral valve endocarditis with sequential linezolid and telavancin monotherapy following daptomycin failure.

Cleveland KO, Memon KA.

J Antimicrob Chemother. 2011 Dec;66(12):2891; author reply 2891-2. doi: 10.1093/jac/dkr369. Epub 2011 Sep 7. No abstract available.

12.

Antibiotic resistance in Enterococcus faecium clinical isolates.

Cattoir V, Giard JC.

Expert Rev Anti Infect Ther. 2014 Feb;12(2):239-48. doi: 10.1586/14787210.2014.870886. Epub 2014 Jan 6. Review.

PMID:
24392717
13.

[Evaluation of the use of antibiotics in the hospital pediatric milieu].

Rasamoelisoa JM, Tovone XG, Andriamady C, Rakotoarimanana DR.

Arch Inst Pasteur Madagascar. 1999;65(1-2):124-6. French.

PMID:
12478978
14.

Trends in antibacterial use in US academic health centers: 2002 to 2006.

Pakyz AL, MacDougall C, Oinonen M, Polk RE.

Arch Intern Med. 2008 Nov 10;168(20):2254-60. doi: 10.1001/archinte.168.20.2254.

PMID:
19001203
15.

Increased use of second-generation macrolide antibiotics for children in nine health plans in the United States.

Stille CJ, Andrade SE, Huang SS, Nordin J, Raebel MA, Go AS, Chan KA, Finkelstein JA.

Pediatrics. 2004 Nov;114(5):1206-11.

PMID:
15520097
16.

Nonadherence to oral linezolid after hospitalization: a retrospective claims analysis of the incidence and consequence of claim reversals.

Ball AT, Xu Y, Sanchez RJ, Shelbaya A, Deminski MC, Nau DP.

Clin Ther. 2010 Dec;32(13):2246-55. doi: 10.1016/S0149-2918(10)80027-X.

PMID:
21316540
17.

Antibacterial agents in pediatrics.

LiPuma JJ, Stull TL.

Infect Dis Clin North Am. 1995 Sep;9(3):561-74. Review.

PMID:
7490433
18.

Rates and appropriateness of antimicrobial prescribing at an academic children's hospital, 2007-2010.

Levy ER, Swami S, Dubois SG, Wendt R, Banerjee R.

Infect Control Hosp Epidemiol. 2012 Apr;33(4):346-53. doi: 10.1086/664761.

PMID:
22418629
19.

Linezolid.

Bell SG.

Neonatal Netw. 2009 May-Jun;28(3):187-92. Review. No abstract available.

PMID:
19451082
20.
Items per page

Supplemental Content

Write to the Help Desk